XBiotech (4XB) Financial Statements

1 Followers

XBiotech Financial Overview

XBiotech's market cap is currently CHF54.04M. The company's EPS TTM is CHF-1.48; its P/E ratio is -1.49; XBiotech is scheduled to report earnings on ―, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 4.01M	$ 18.39M
Gross Profit	$ -1.69M	$ 0.00	$ 0.00	$ 3.36M	$ 12.57M
Operating Income	$ -55.69M	$ -42.47M	$ -37.51M	$ -34.49M	$ -25.08M
EBITDA	$ -43.53M	$ -36.01M	$ -22.57M	$ -30.97M	$ -22.81M
Net Income	$ -45.54M	$ -38.53M	$ -24.56M	$ -32.90M	$ -17.41M
Balance Sheet
Cash & Short-Term Investments	$ 125.55M	$ 172.68M	$ 200.02M	$ 217.48M	$ 236.98M
Total Assets	$ 150.08M	$ 199.09M	$ 226.62M	$ 246.10M	$ 275.18M
Total Debt	$ 0.00	$ 10.25M	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -125.55M	$ -162.43M	$ -200.02M	$ -157.31M	$ -236.98M
Total Liabilities	$ 9.73M	$ 16.82M	$ 7.77M	$ 5.70M	$ 5.79M
Stockholders' Equity	$ 140.35M	$ 182.27M	$ 218.85M	$ 240.40M	$ 269.38M
Cash Flow
Free Cash Flow	$ -40.21M	$ -32.27M	$ -19.09M	$ -15.41M	$ 65.92M
Operating Cash Flow	$ -39.92M	$ -30.96M	$ -18.73M	$ -14.82M	$ 69.44M
Investing Cash Flow	$ -289.00K	$ -1.30M	$ 61.50M	$ -63.89M	$ -3.52M
Financing Cash Flow	$ -10.25M	$ 10.45M	$ -9.00K	$ 0.00	$ -67.01M

Currency in USD

XBiotech Earnings and Revenue History

Income Statement >

XBiotech Debt to Assets

Balance Sheet >

XBiotech Cash Flow

Cash Flow >

XBiotech Forecast EPS vs Actual EPS

Earnings >